GREM1 and lung carcinoma: For other IRGs, such as LGR4, GDF10, GREM1, IL20RB, INHA, VIPR1, and ADM2, they had been verified to participate in carcinogenesis and affect patients’ prognoses in other cancers, although the relevant studies were rare in lung cancer [27–34].